GWW
53
12
PFE
47
15
FMC
31
-3
RIG
25
-3
HD
40
-3
LB
62
-7
A
43
2
VNO
54
2
AAPL
55
3
ILMN
25
2
RRC
68
-2
VZ
54
2
COF
62
2
MU
48
-7
GD
57
-2
TSCO
50
5
XEL
60
-9
HSIC
54
-2
NUE
36
-7
MOS
53
-5
GWW
53
12
PFE
47
15
FMC
31
-3
RIG
25
-3
HD
40
-3
LB
62
-7
A
43
2
VNO
54
2
AAPL
55
3
ILMN
25
2
RRC
68
-2
VZ
54
2
COF
62
2
MU
48
-7
GD
57
-2
TSCO
50
5
XEL
60
-9
HSIC
54
-2
NUE
36
-7
MOS
53
-5
Financhill
Back

Regions Financial Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
63

RF
Regions Financial

Last Price:
$21.68
Seasonality Move:
1.97%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$283.22
Seasonality Move:
3.3%
Buy
63
Regions Financial (RF) is a Buy

Is Regions Financial a Buy, Sell or Hold?

  • The current Regions Financial [RF] share price is $21.71. The Score for RF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • RF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RF Stock Price Chart

What is Regions Financial's stock price today?

  • The Regions Financial share price today is $21.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RF is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 38.96 Sell
Chaikin Money Flow: 26736686 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.48 - 23.88) Sell
Bollinger Bands (100): (22.78 - 25.82) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

RF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.44 Buy
20-day SMA: 22.27 Sell
50-day SMA: 23.48 Sell
200-day SMA: 22.87 Sell
8-day EMA: 21.66 Buy
20-day EMA: 22.21 Sell
50-day EMA: 23.13 Sell
200-day EMA: 22.81 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

Regions Financial Earnings Growth & RF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.16 per share, and an increase next year of $0.23 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

Regions Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):